Copyright: ©Author(s) 2026.
World J Methodol. Sep 20, 2026; 16(3): 116058
Published online Sep 20, 2026. doi: 10.5662/wjm.116058
Published online Sep 20, 2026. doi: 10.5662/wjm.116058
Table 7 Adverse event patterns from individual studies
| Adverse event | Propofol studies | Etomidate studies | Ketamine studies | Ketofol studies |
| Nausea/vomiting | Lower rates reported across studies | Higher rates consistently reported | Variable rates across studies | Intermediate rates reported |
| Myoclonus | Minimal occurrence reported | Frequently reported across studies | Low occurrence reported | Low to moderate occurrence |
| Emergence phenomena | Rare occurrence | Occasional reports | Frequently reported concern | Occasional reports |
| Prolonged recovery | Minimal reports | Moderate occurrence | Consistent reports across studies | Variable reports |
| Hypotension | Occasional reports | Rare occurrence | Minimal reports | Occasional reports |
| Hypertension | Rare occurrence | Rare occurrence | Frequently reported | Moderate occurrence |
- Citation: Tilokani H, Jawed I, Shehzadi A, Ali A, Khan A, Qadir U, Bin Gulzar AH, Zahid R, Khan S, Mal M, Zakeri MA, Aslam H, Siddique MU. Impact of different anesthetic agents (propofol, etomidate, ketamine) on seizure duration and cognitive recovery in electroconvulsive therapy. World J Methodol 2026; 16(3): 116058
- URL: https://www.wjgnet.com/2222-0682/full/v16/i3/116058.htm
- DOI: https://dx.doi.org/10.5662/wjm.116058